US Government to Spend $5 Billion Using AI to Crack Chronic Disease and Drug Discovery
Fifteen federal agencies will share the funding and gain access to powerful government supercomputers to run AI experiments on some of science's hardest problems.
Key points
- The Trump administration announced $5 billion in federal funding for AI-driven scientific research on Wednesday.
- Fifteen US government agencies will receive a share of the money.
- Goals include finding the root causes of chronic diseases, speeding up drug discovery, and developing longer-lasting building materials.
- Scientists will get access to Department of Energy supercomputers, specialised datasets, and AI tools to run experiments.
- The administration also plans to shift how it funds research, favouring individual scientists and AI projects over universities.
The Trump administration announced on Wednesday that the United States will spend $5 billion to put artificial intelligence, the technology behind tools like ChatGPT and Google Search, to work on some of science's oldest and hardest problems.
Fifteen federal agencies will share the funding. Their stated targets are ambitious: uncover what actually causes chronic illnesses, find new medicines faster, and build materials that last longer.
Michael Kratsios, chief technology adviser to President Donald Trump, told Reuters that scientists taking part will get access to the Department of Energy's supercomputers, which are machines thousands of times more powerful than a typical laptop, along with specialised AI tools and datasets, the large organised collections of data that AI systems learn from.
The practical idea is straightforward. Running experiments in the physical world is slow and expensive. AI can sift through enormous amounts of existing research and data, spot patterns humans would miss, and suggest which experiments are worth trying next. That process, if it works as promised, could cut years off the timeline for a new drug or medical treatment reaching patients.
What does this mean for ordinary people?
If the programme delivers, patients with conditions like diabetes, heart disease, or cancer could see better treatments arrive sooner than they would have otherwise. That is the ambition. The caveat is real: large government science programmes often take many years to produce results that anyone outside a laboratory can feel.
The announcement also signals a shift in how the federal government hands out research money. Rather than routing most funding through universities, the administration says it wants to direct more cash straight to individual scientists and AI-focused projects. That change worries some researchers, since universities provide the shared labs, equipment, and support staff that make independent science possible. The administration has not yet detailed exactly how that new model would work in practice.
The Guardian AI first reported the core details of the announcement. Full specifics on which agencies receive which portions of the $5 billion, and on what timeline, had not been released at the time of publication.
